Angelica Lin

Angelica Lin

Auto-generated profile, based on publicly available information

Angelica Lin

Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2023 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
WZWeihua Zhou
Weihua Zhou
ZZZitong Zhao
Zitong Zhao
ALAngelica Lin
Angelica Lin
JYJohn Z. Yang
John Z. Yang
JXJie Xu
Jie Xu
Daniel R. WahlDaniel R. Wahl
Daniel R. Wahl
How cell metabolism regulates DNA repair is incompletely understood. Here, we define a GTP-mediated signaling cascade that links metabolism to DNA repair and has significant therapeutic implications. GTP, but not other nucleotides, regulates the activity of Rac1, a guanine nucleotide-binding protein, which promotes the dephosphorylation of serine 323 on Abl-interactor 1 (Abi-1) by protein phosphatase 5 (PP5). Dephosphorylated Abi-1, a protein previously not known to activate DNA repair, promotes nonhomologous end joining. In patients and mouse models of glioblastoma, Rac1 and dephosphorylated Abi-1 mediate DNA repair and resistance to standard-of-care genotoxic treatments. The GTP–Rac1–PP5–Abi-1 signaling axis is not limited to brain cancer, as GTP supplementation promotes DNA repair and Abi-1-S323 dephosphorylation in nonmalignant cells and protects mouse tissues from genotoxic insult. This unexpected ability of GTP to regulate DNA repair independently of deoxynucleotide pools has important implications for normal physiology and cancer treatment. SIGNIFICANCE: A newly described GTP-dependent signaling axis is an unexpected link between nucleotide metabolism and DNA repair. Disrupting this pathway can overcome cancer resistance to genotoxic therapy while augmenting it can mitigate genotoxic injury of normal tissues. This article is featured in Selected Articles from This Issue, p. 5

12 January 2024
Verified
Other
Open access
PDF file
WZWeihua Zhou
Weihua Zhou
ZZZitong Zhao
Zitong Zhao
ALAngelica Lin
Angelica Lin
JYJohn Z. Yang
John Z. Yang
JXJie Xu
Jie Xu
Daniel R. WahlDaniel R. Wahl
Daniel R. Wahl
Supplementary Table S1 shows Supplementary Table S1 and relative references.

12 January 2024
Verified
Other
Open access
PDF file
WZWeihua Zhou
Weihua Zhou
ZZZitong Zhao
Zitong Zhao
ALAngelica Lin
Angelica Lin
JYJohn Z. Yang
John Z. Yang
JXJie Xu
Jie Xu
Daniel R. WahlDaniel R. Wahl
Daniel R. Wahl
Supplementary Data 2 shows Supplementary Methods, Supplementary Reference, Supplementary Figure S1 and Figure Legends, Supplementary Figure S2 and Figure Legends, Supplementary Figure S3 and Figure Legends, Supplementary Figure S4 and Figure Legends, Supplementary Figure S5 and Figure Legends, Supplementary Figure S6 and Figure Legends, and Supplementary Figure S7 and Figure Legends.

12 January 2024
Verified
Other
Open access
WZWeihua Zhou
Weihua Zhou
ZZZitong Zhao
Zitong Zhao
ALAngelica Lin
Angelica Lin
JYJohn Z. Yang
John Z. Yang
JXJie Xu
Jie Xu
Daniel R. WahlDaniel R. Wahl
Daniel R. Wahl
Supplementary Data 1 shows the original data of phosphoproteomic assay in Figure 2.

12 January 2024
Verified
Other
Open access
WZWeihua Zhou
Weihua Zhou
ZZZitong Zhao
Zitong Zhao
ALAngelica Lin
Angelica Lin
JYJohn Z. Yang
John Z. Yang
JXJie Xu
Jie Xu
Daniel R. WahlDaniel R. Wahl
Daniel R. Wahl
Supplementary Data 1 shows the original data of phosphoproteomic assay in Figure 2.

12 January 2024
Verified
Other
Open access
PDF file
WZWeihua Zhou
Weihua Zhou
ZZZitong Zhao
Zitong Zhao
ALAngelica Lin
Angelica Lin
JYJohn Z. Yang
John Z. Yang
JXJie Xu
Jie Xu
Daniel R. WahlDaniel R. Wahl
Daniel R. Wahl
Supplementary Data 2 shows Supplementary Methods, Supplementary Reference, Supplementary Figure S1 and Figure Legends, Supplementary Figure S2 and Figure Legends, Supplementary Figure S3 and Figure Legends, Supplementary Figure S4 and Figure Legends, Supplementary Figure S5 and Figure Legends, Supplementary Figure S6 and Figure Legends, and Supplementary Figure S7 and Figure Legends.